» Articles » PMID: 35991924

Comparison of Fluorescence Lifetime and Multispectral Imaging for Quantitative Multiplexing in Biological Tissue

Overview
Specialty Radiology
Date 2022 Aug 22
PMID 35991924
Authors
Affiliations
Soon will be listed here.
Abstract

Fluorescence lifetime (FLT) multiplexing and multispectral imaging (MSI) are both frequently employed for and biological studies. applications of MSI for deep seated fluorophores require consideration of diffusive light propagation in biological tissue. We have previously shown that a well-known redshift of fluorescence spectra in diffusive medium induces a fluorophore cross-talk, which cannot be accounted for even with known optical properties of the medium. In contrast, FLT measurements remain largely unaffected by light propagation in tissue, enabling zero cross-talk and accurate relative quantification. While a fully quantitative estimation of fluorophore concentrations requires depth resolved tomographic imaging, this is often not possible due to the difficulty of estimating tissue optical properties and modelling light propagation in complex tissue geometries. Here, we experimentally investigate the performance of planar (non-tomographic) MSI and FLT multiplexing for the quantitative recovery of multiple near-infrared fluorophores embedded in 4-8 mm thick tissue. We show that FLT multiplexing provides a superior quantification accuracy (error < 10%) compared to MSI (error = 20-107%) in tissue. The error rates for MSI increased with tissue thickness and can be directly attributed to the spectral redshift induced cross-talk between emission spectra. Our data indicate that planar FLT multiplexing can provide high quantification accuracy in thick biological tissue without a need for optical property estimation, thereby offering an important validation tool for rapid quantification of fluorophore concentrations in bulk tissue.

Citing Articles

quantification of programmed death-ligand-1 expression heterogeneity in tumors using fluorescence lifetime imaging.

Pal R, K M, Matsui A, Kang H, Morita S, Taniguchi H Res Sq. 2023; .

PMID: 37961361 PMC: 10635296. DOI: 10.21203/rs.3.rs-3222037/v1.


Intraoperative molecular imaging: 3rd biennial clinical trials update.

Bou-Samra P, Muhammad N, Chang A, Karsalia R, Azari F, Kennedy G J Biomed Opt. 2023; 28(5):050901.

PMID: 37193364 PMC: 10182831. DOI: 10.1117/1.JBO.28.5.050901.


Erratum: Comparison of fluorescence lifetime and multispectral imaging for quantitative multiplexing in biological tissue: erratum.

Pal R, Kumar A Biomed Opt Express. 2023; 13(11):5738-5739.

PMID: 36733733 PMC: 9872866. DOI: 10.1364/BOE.476976.

References
1.
Rice W, Shcherbakova D, Verkhusha V, Kumar A . In vivo tomographic imaging of deep-seated cancer using fluorescence lifetime contrast. Cancer Res. 2015; 75(7):1236-43. PMC: 4383673. DOI: 10.1158/0008-5472.CAN-14-3001. View

2.
Hiraoka Y, Shimi T, Haraguchi T . Multispectral imaging fluorescence microscopy for living cells. Cell Struct Funct. 2002; 27(5):367-74. DOI: 10.1247/csf.27.367. View

3.
Bhalla R, Hulsemann M, Verkhusha P, Walker M, Shcherbakova D, Hodgson L . Multiplex Imaging of Rho GTPase Activities in Living Cells. Methods Mol Biol. 2021; 2350:43-68. PMC: 8367095. DOI: 10.1007/978-1-0716-1593-5_4. View

4.
Han H, Kang H, Kim S, Pal R, Kumar A, Choi H . Fluorescent nanodiamond - hyaluronate conjugates for target-specific molecular imaging. RSC Adv. 2021; 11(37):23073-23081. PMC: 8240508. DOI: 10.1039/d1ra03936a. View

5.
Pal R, Kang H, Choi H, Kumar A . Fluorescence Lifetime-Based Tumor Contrast Enhancement Using an EGFR Antibody-Labeled Near-Infrared Fluorophore. Clin Cancer Res. 2019; 25(22):6653-6661. PMC: 6858968. DOI: 10.1158/1078-0432.CCR-19-1686. View